Compare IRT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRT | AMRX |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | 2013 | N/A |
| Metric | IRT | AMRX |
|---|---|---|
| Price | $16.98 | $12.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $21.56 | $13.25 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | ★ 4.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.09 | 0.02 |
| Revenue | $662,924,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $4.19 | $9.99 |
| Revenue Next Year | $4.72 | $6.67 |
| P/E Ratio | ★ $185.79 | $758.81 |
| Revenue Growth | 3.19 | ★ 9.50 |
| 52 Week Low | $15.07 | $6.69 |
| 52 Week High | $21.89 | $12.68 |
| Indicator | IRT | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.91 | 63.33 |
| Support Level | $16.32 | $12.12 |
| Resistance Level | $17.14 | $12.43 |
| Average True Range (ATR) | 0.32 | 0.31 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 67.29 | 81.43 |
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.